Cannabis Stocks Drop As FDA Warns About CBD Effects: ‘It Has Potential To Harm’- By Arthur Villasanta (IB Times) / Nov 26 2019
Canada’s world leading cannabis producers took a huge hit on Canada’s stock exchanges and Wall Street Tuesday after the U.S. Food and Drug Administration (FDA) warned the marijuana compound cannabidiol (CBD) can cause liver injury and other damage to the human body.
The worldwide cannabis industry is relying heavily on CBD to fulfill its promise as a legitimate multi-billion dollar industry. Among the health benefits attributed to CBD by anecdotal evidence include the relief of anxiety, arthritis pain, depression, inflammatory pain, nausea and vomiting associated with cancer and nerve-related pain.
CBD is currently marketed in a variety of product forms. These include topicals such as oil drops, topical lotions and creams. CBD is also imbibed as capsules, syrups and food products such as chocolate bars and teas.
On Monday, the FDA slammed CBD in its strongest language yet. Its updated guidance claims CBD “has the potential to harm you, and harm can happen even before you become aware of it.”
FDA said the lack of scientific evidence about CBD means it can’t conclude CBD is “generally recognized as safe among qualified experts for use in human and animal food.”
Continue to article: https://www.ibtimes.com/cannabis-stocks-drop-fda-warns-about-cbd-effects-it-has-potential-harm-2874233
